Lipoic acid improves glucose utilisation and prevents protein glycation and AGE formation

Pharmazie

Volumn 60, Issue 10, 2005, Pages 772-775

  Thirunavukkarasu, V ^a   Anitha Nandhini, A T ^a   Anuradha, C V ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSAMINE; FRUCTOSE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; THIOCTIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIAPHRAGM; DRUG EFFECT; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; GLYCATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN GLYCOSYLATION; RAT;

ALBUMINS; ANIMALS; CATS; DIAPHRAGM; FRUCTOSAMINE; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; MALE; OXIDANTS; PROTEINS; RATS; SPECTROMETRY, FLUORESCENCE; THIOCTIC ACID;

EID: 27144475805     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Alvarez S, Boveris A (1995) Lipoic acid and the prevention of oxidative damage. Cienca Cultura 47: 358-361.
2. Blakytny R, Harding JJ (1992) Prevention of cataract in diabetic rat by aspirin, paracetamol and ibuprofen. Exp Eye Res 54: 509-518.
3. Borenshtein D, Ofri R, Werman M, Stark A, Tritschler HJ, Moeller W et al. (2001) Cataract development in diabetic sand rats treated with olipoic acid and its gamma-linolenic acid conjugate. Diab Metab Res Rev 17: 44-50.
4. Bucala, R (1999) Advanced glycosylation end products and diabetic vascular disease, pp. 213-243. In: Oxidative stress and vascular disease. JF Jr Keaney (eds.) pp. 373, Kluwer Academic Publishers, Dordrecht.
5. Coleman MD, Eason RC, Bailey CJ (2001) The therapeutic use of lipoic acid in diabetes: a current perspective. Environ Toxicol Pharmacol 10: 167-172.
6. Dargel R (1992). Lipid peroxidation-a common pathogenic mechanism? Exp Toxic Pathol 44: 169-181.
7. Evans JL, Goldfine ID (2000) Alpha lipoic acid: A multifactorial antioxidant that improves insulin sensitivity in patients with type 2 diabetes. Diab Technol Ther 2: 401-413.
8. Ford I, Cotter MA, Cameron NE, Greaves M (2001) The effects of treatment with α-lipoic acid or evening primrose oil on vascular hemostatic and lipid risk factors, blood flow, and peripheral nerve conduction in the streptozotocin-diabetic rat. Metabolism 50: 868-875.
9. Harnett ME, Stratton RD, Browne RW, Rosher BA, Lanham RJ, Armstrong D (2000) Serum markers for oxidative stress and severity of diabetic retinopathy. Diab Care 23: 234-240.
10. Haugaard N, Haugaard SE (1970) Stimulation of glucose utilization by thioctic acid in rat diaphragm incubated in vitro. Biochim Biophys Acta 222: 583-586.
11. Henriksen EJ, Jacob S, Streeper RS, Fogt PL, Hokama JY, Tritschler HJ (1997) Stimulation by α-lipoic acid of glucose transport activity in skeletal muscle of lean and obese Zucker rats. Life Sci 16: 805-812.
12. Jacob S, Henriksen EJ, Schiemann AL, Simon I, Clancy DE, Tritschler HJ et al. (1995) Enhancement of glucose disposal in patients with type 2 diabetes by α-lipoic acid. Arzneim-Forsch (Drug Res) 45: 872-874.
13. Jacob S, Henriksen EJ, Tritschler HJ, Augustin HJ, Dietze GJ (1996) Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parentral administration of thioctic acid. Exp Clin Endocrinol Diabetes 104: 284-288.
14. + ATPases activities in high glucose-treated human erythrocytes. Free Rad Biol Med 29: 1122-1128.
15. Johnson RN, Metealf PA, Baker JR (1983) Fructosamine: a new approach to the estimation of serum glycosylation. An index of diabetic control. Clin Chim Acta 217: 87-95.
16. Maxwell SRJ, Thomason H, Sandier D, Le Guen C, Baxter MA, Thorpe GHG et al. (1997) Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin dependent-diabetes mellitus. Eur J Clin Invest 27: 484-490.
17. Misur I, Turk Z (2001) Substituted guanidine compounds as inhibitors of nonenzymatic glycation in vitro. Croatica Chemica Acta 74(2): 455-465.
18. Mullarkey CJ, Edelstein D, Brownlee, M (1990) Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 173: 932-939.
19. Natraj CV, Gandhi VM, Menon KKG (1984) Lipoic acid and diabetes. Effect of dihydrolipoic acid administration in diabetic rats and rabbits. J Biosci 6: 37-46.
20. Packer L, Witt EH, Tritschler HJ (1995) α-lipoic acid as a biological anti-oxidant. Free Rad Biol Med 19: 227-250.
21. Rao P, Pattabiraman TN (1990) Further studies on the mechanism of phenol sulfuric acid reaction with furfuraldehyde derivatives. Anal Biochem 189: 178-181.
22. Sasaki T, Matsui S, Sonae A (1972) Effect of acetic acid concentration on the colour reaction in the o-toluidine boric acid method for blood glucose estimation. Rinshokagaku 1: 346-353.
23. Schauenstein E, Esterbauer H, Zollner H (1977) In: Aldehydes in biological systems, their natural occurrence and biological activities, pp. 1-7, Pion Limited, London.
24. Strodter D, Lehmann E, Lehmann V, Tritschler HJ (1995) The influence of thioctic acid on metabolism and function of the diabetic heart. Diab Res Clin Pract 29: 19.
25. Thornalley P, Wolff S, Crabbe J, Stern A (1993) The autoxidation of glyceraldehydes and other simple monosaccharides under physiological conditions catalysed by buffer ions. Biochm Biophys Acta 797: 276-287.
26. Turk, Z (1997) Advanced glycation toxicity and diabetic complications. Diabetol Croat 26: 11-26.
27. Vasdev S, Ford CA, Parai S, Longerich L, Gadag V (2000) Dietary lipoic acid supplementation prevents fructose-induced hypertension in rats. Nutr Metab Cardiovasc Dis 10: 339-346.
28. Vinson AJ, Howard BT (1996) Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J Nutr Biochem 7: 659-663.
29. Vlassara H, Bucala R, Striker L (1994) Pathogenic effect of advanced glycosylation: biochemical, biologic and clinical implications for diabetes and aging. J Lab Investig 70: 138-151.
30. Wolff SP, Jiang XY, Hunt JV (1991) Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Rad Biol Med 10: 339-352.
31. Yanagisawa K, Makita Z, Shiroshita K et al. (1998) Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patients. Metabolism 47: 1348-1353.
32. Yaworsky K, Somwar R, Ramlal T, Tritschler HJ, Klip A (2000) Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by α-lipoic acid in 3T3-L1 adipocytes. Diabetologia 43: 294.
33. Ziegler D, Hanfield M, Ruhnau KJ, Hasche H, Lobisch M, Schutte K et al. (1999) Treatment of symptomatic diabetic polyneuropathy with the anti-oxidant α-lipoic acid. Diab Care 22: 1296-1301.